Rubin, A-H. E. and Alroy, G. G. (1977) . Thorax, 32, [373] [374] [375] [376] . Candida albicans abscess of lung. Candida albicans lung abscess is a rare entity. We present a case in a patient who suffered from Hodgkin's disease and was receiving immunosuppressive therapy. The patient responded to treatment with 5-fluorocytosine.
rhe importance of Candida species as pathogens has increased in the past few years. Systemic candidiasis and Candida organ involvement as haematogenous chorioretinitis, osteomyelitis, and skin infection have been described (Hughes and Remington, 1972; Fishman et al., 1972; Balandran et al., 1973; Edwards et al., 1975) .
We present a case of lung abscess due to Candida albicans in a patient with deficient immunity. This entity is rare but might prove to be of increasing importance.
Case report
A 49-year-old man was diagnosed in April 1973 as suffering from Hodgkin's disease, lymphocytic depleted type, grade IJI B. Splenectomy was performed and large, hard, para-aortic lymph-nodes were found at laparotomy. Treatment was begun with MOPP' according to routine protocol (De Vita et al., 1970 9.4 g/dl, WBC 3 6X 109 1-1 with 37% band forms.
Protein electrophoresis was normal. A chest radiograph ( Fig. 1) showed a homogenous opacity in the right middle lobe and an opacity at the left 'Nitrogen mustard, vincristine, procarbazine, and prednisone base. Sputum culture showed a rich growth of Klebsiella, Enterobacteria, and Candida albicans. Blood cultures were sterile.
In view of these results treatment was begun with crystalline penicillin, 6 mega units daily, and gentamicin, 80 mg three times a day intravenously for one week without any beneficial effect. Treatment was then changed to cephalexin, 3 g daily, and gentamicin, 80 mg twice daily, also without any improvement. During this time (2 weeks) a cavity containing a central opacity developed in the right middle lobe (Fig. 2) .
From this time on all sputum cultures showed a pure growth of Candida albicans. Treatment was changed to 5-fluorocytosine (5-FC) in a dose of 100 mg/kg per day orally. During the course of one week there was a dramatic clinical improvement and a gradual radiographic improvement (Fig. 3) . Treatment was continued for eight weeks and at the end of five months the lung abscess had disappeared (Fig. 4) and he then resumed MOPP treatment.
Discussion
It is difficult to estimate the true frequency of candidiasis of the lung, but most authorities agree on the extreme rarity of primary Candida bronchopneumonia (Spencer, 1968 lung abscess (Isacson et al., 1972; Chidi and Mendelsohn, 1974; Firkin, 1974) . Our patient's immunological system was depressed by his illness and by the immunosuppressive treatment, as shown by the systemic herpes zoster he developed a year before. In addition, the massive antibiotic therapy given early in the course of the present admission could have resulted in the development of the Candida lung abscess by suppression of the bacteria competing with Candida.
According to Isacson et al. (1972) , four criteria are necessary for the diagnosis of systemic candidiasis: (1) positive cultures for Candida; (2) suspicious clinical features; (3) the presence of predisposing factors; and (4) a good response to specific antifungal treatment.
Our patient fulfilled these criteria despite the negative blood culture which was outweighed, in our opinion, by six positive sputum cultures. In addition, the radiographic appearances are suggestive of a 'fungus ball'.
The patient responded well to treatment with 5-FC in a dosage of 100 mg/kg/day. 5-FC is an antimetabolite of the pyrimidine base cytosine, known to have a high degree of activity against Candida, but having relatively little toxcity in man. However, it should be emphasised that the tendency today is to recommend treatment of systemic candidiasis with both 5-FC and amphotericin B owing to their synergistic action in vitro and to prevent the development of resistance to the 5-FC (Montgomerie et al., 1975) .
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